Edan Instruments

Edan Instruments Operating Expenses

The Total Operating Expenses of Edan Instruments (300206.SZ) as of Oct 27, 2026 is 488.59 M CNY. In the previous year, Total Operating Expenses was 461.03 M CNY — a change of 5.98% (higher).

Operating Expenses

488.59 MCNY

YoY

5.98%

Last updated:

Total Operating Expenses of Edan Instruments is 2025 488.59 M CNY. Total Operating Expenses of Edan Instruments was 2024 461.03 M CNY. It decreases by 5.98% higher compared to the previous year.

The Edan Instruments Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
265.86 M CNY
Jan 1, 2019
285.35 M CNY
Jan 1, 2020
318.66 M CNY
Jan 1, 2021
356.91 M CNY
Jan 1, 2022
413.22 M CNY
Jan 1, 2023
463.40 M CNY
Jan 1, 2024
461.03 M CNY
Jan 1, 2025
488.59 M CNY
The Edan Instruments Operating Expenses history
YEAROperating ExpensesYoY
488.59 MCNY+5.98%
461.03 MCNY-0.51%
463.40 MCNY+12.14%
413.22 MCNY+15.78%
356.91 MCNY+12.00%
318.66 MCNY+11.68%
285.35 MCNY+7.33%
265.86 MCNY+3.95%
255.76 MCNY-34.28%
389.19 MCNY+11.76%
348.23 MCNY+2.65%
339.23 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edan Instruments stock

Total Operating Expenses of Edan Instruments is 488.59 M CNY in 2025.

Total Operating Expenses of Edan Instruments changed from 461.03 M CNY to 488.59 M CNY, representing a 5.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Edan Instruments historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Edan Instruments

All Key Metrics — Edan Instruments